differentiation of the SKT6 murine erythroleukemia cell line,23 whereas transfected c-myb sequences inhibit both erythropoietin-mediated SKT6 differentiation as well as chemically induced differentiation of F-MELC. 23-2s The relationship between cellular proliferation and differentiation suggests that deregulated expression of nuclear protooncogenes may, under some circumstances, radically alter the stochastic balance that exists between perpetual selfrenewal and terminal differentiation.
With these ideas in mind, we were interested in exploring the relationships between other nuclear proto-oncogenes and hematopoietic differentiation. To this end, we have investigated the expression and regulation of members of the jun family in F-MELC. The jun family is comprised of at least three distinct but closely related genes<-jun, junB, and junD-which are induced, although to different extents, in growth factor or phorbol diester-stimulated quiescent ~e l l s .~~-~' All three are nuclear DNA binding proteins that recognize a common structural motif, the 12-0-tetradecanoylphorbol 13-acetate (TPA) response element (TRE).32*33 DNA binding occurs after dimerization with other jun family members but is enhanced approximately 25-fold when combined in heterodimeric association with the c-fos p r o d~c t .~~.~~ The interchangeability of a limited number of components offers the potential for multiple combinatorial possibilities, each with unique transcriptional specificities.
We now report that constitutive expression of any of the three known jun family members blocks F-MELC differentiation. This is not a general property of immediate early response genes, because the transfection of F-MELC with another such gene, egr-1 , 41 resulted in no discernible effect on differentiation.
MATERIALS AND METHODS

Construction of recombinant plasmids.
The starting vector for all expression constructs was pSV,dhfr, which was derived from the plasmid pSV,neo4' by removing neo coding sequences with Hind111 and SmaI and inserting a SmaI linker. A 2.8-kb PstI-Sa11 fragment from the plasmid ~F R 4 0 0 ;~ containing a complete transcription unit for a mutant murine dihydrofolate reductase (dhfr) enzyme, was modified by the addition of EcoRI linkers and cloned into the unique EcoRI site of the modified pSV,neo plasmid.
A full-length murine c-jun cDNA was kindly provided by Dr R. Bravo3' (European Molecular Biology Laboratory, Heidelburg, were excised from their plasmid vectors as IS-kb, 1.7-kb. and 3.2-kb EcoRI fragments, respectively, blunt-ended with Klenow DNA polymerase, and ligated into SmaI-digested pSV,dhfr as described above (Fig 1) . For DNA transfections into F-MELC, the above DNAs were first linearized with NdeI or BglI, which recognize unique restriction sites within the pBR322 plasmid backbone. Forty micrograms of linearized DNA was combined with 2 to 3 pg of EcoRI-linearized pSV2neo4, in 50 pL of sterile water for electroporation into F-MELC.
A subclone of the F-MELC clone 745, designated clone 25, was used for all DNA transfections. This clone and derived subclones routinely gave greater than 80% benzidine positive cells during a 5-day exposure to 1.5% dimethyl sulfoxide (DMSO). Cells were grown in Dulbecco's modified minimal essential medium (MEM) containing 10% supplemented calf serum (Hyclone, Logan, UT), 100 U/mL penicillin G, 100 pg/mL streptomycin, and 2 mmol/L glutamine. Cells were cultured at 37OC in a humidified 5% CO, atmosphere. For DNA transfections, 2 x IO' logarithmically growing F-MELCs were washed in phosphatebuffered saline (PBS), and resuspended in 0.5 mL of ice cold PBS. F-MELCs were then electroporated as previously d e~c r i b e d . '~.~~ After a IO-minute incubation on ice, cells were plated into 30 mL of MEM in a 150-mm plastic Petri dish. Two days later, G-418 (Geneticin, GIBCO, Grand Island, NY) was added to a final absolute concentration of 0.5 mg/mL. G-418-resistant clones were subsequently subjected to a second round of selection in 0.25-pmol/L methotrexate (MTX, Lederle Laboratories, Wayne, NJ). MTX-resistant survivors were cloned by limited dilution in 96-well microtiter plates.
Logarithmically growing cells were seeded at densities of approximately 5 x 104/mL in 35-mm tissue culture dishes. DMSO was added to a final Concentration of 1.5%. Cultures were fed with fresh DMSO-containing medium on day 3. One hundred-microliter aliquots of cells were removed daily to assess Cell culture and DNA transfections.
Benzidine staining. RNA was prepared by the guanidineHCl method as .previously d e~c r i b e d . '~. '~.~~ All samples were examined on agarose formaldehyde gels to ensure equality of concentrations and intactness. SI nuclease protection assays were performed as previously described using end-labeled probes specific for each expression plasmid (Fig 1 through 4) . Each probe was end labeled with '2P-y-ATP (Amersham, Arlington Heights, IL) and polynucleotide kinase to specific activities of 2 to 5 x IO' dpm/pg." Each hybridization reaction contained 10 pg of total RNA and IO5 dpm of single-stranded probe. Nuclease S 1 concentrations in all cases were 200 U/mL.
Nucleic acid analyses.
For E.rpression ofegr-l and junfomil,,, membrJ in diferentiating F-MELC. We first studied the expression of c-jim. Several randomly selected clones from each group were examined for the expression of c-jun. jun0, j u d . and egr-l transcripts using the end-labeled S1 nucleasa probes de- Fig 2) .
-'" Numbers above r c h iane indi-
-34%
cate individual clones. Control lanes (cl contained RNAs from an uncloned population of F-MELC t r a n s f e c t e d with pSV,dhfr vector sequences only.
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In the case of c-jun, we were unable to detect transcripts a t any of the times chosen in logarithmically growing DMSOtreated F-MELC (not shown). However, we could detect c-jun transcripts if F-MELC was first rendered quiescent and then stimulated to re-enter the cell cycle. Under these conditions, c-jun transcripts were detected as early as 15 to 30 minutes following stimulation and persisted for greater than 2 hours (Fig 2) . We were also able to detect c-jun transcripts in logarithmically growing F-MELCs if the cells were treated for 4 hours with cycloheximide (CHX), an inhibitor of protein synthesis, which in combination with growth factors has been reported to increase the rate of c-jun gene transcription as well as to stabilize pre-existing c-jun mRNAs.28.31 46-47 Thus, under conditions of normal logarithmic growth and during DMSO-induced differentiation, c-jun transcripts are expressed at extremely low levels. Low levels of c-jun expression have also been reported in F9 murine teratocarcinoma cells. 46 In contrast to c-jun, transcripts for junB, junD, and egr-1 were easily detected in differentiating F-MELC using specific nuclease protection assays (Fig 3) . Of note was that endogenous junB transcripts were modulated over the 5-day course of the experiment, whereas transcripts for junD and egr-1 remained constant. JunB transcripts were expressed a t approximately equivalent levels until 8 to 24 hours after DMSO addition, when they decreased approximately 10-to 20-fold. They then increased gradually, reaching levels somewhat higher than those in uninduced F-MELC by 5 days. Similar levels of junB expression were observed when F-MELCs were stimulated to differentiate with the structurally unrelated agent hypoxanthine (unpublished observations, January 1990).
In summary, the expression and regulation of jun family member transcripts in DMSO-treated F-MELC differ despite the overall similarity in structure and function of the gene products. c-jun transcripts are undetectable in logarithmically growing F-MELC unless superinduced in the presence of CHX. junB and junD transcripts on the other hand, are easily detected in F-MELCs. junD transcripts are not regulated during differentiation, whereas those for junB show a transient decline between 8 and 24 hours after DMSO addition.
Molecular analysis of individual jun-transfected F-MELC clones. F-MELCs were transfected with linearized DNA from each of the expression vectors shown in Fig 1. As controls, F-MELCs were also transfected with pSV,dhfr vector sequences only. Stable transfectants were generated by sequential selection in G-418 and MTX, and 10 to 20 individual clones from each group were obtained by limited dilution. Randomly selected clones from each group were examined for the integration and expression of transfected sequences.
In the case of pSV,c-jun-dhfr-transfected clones, eight of eight clones examined contained unrearranged c-jun sequences. Seven of seven expressed high levels of transfected c-jun sequences (Fig 4A and unpublished observations,  January 1990 ). Due to the low levels of endogenous c-jun transcripts in F-MELCs (Fig 2) , it was not possible to determine the ratios of endogenous to exogenous transcripts. However, exogenous levels were, on average, a t least 10 to 20 times higher than the endogenous superinduced levels seen in CHX-treated logarithmically growing F-MELCs (Fig 2B) .
In the case of pSVjunB-dhfr-transfected cells, 9 of the 10 clones examined contained unrearranged junB sequences (not shown). Eight of these nine clones were examined for the expression of junB transcripts. In all eight cases, transfected junB sequences were expressed a t levels 1 to 20 times those of endogenous junB transcripts (Fig 4B) .
Nine of nine pSVjunD-dhfr transfected clones examined contained unrearranged plasmid sequences (not shown). Seven clones were analyzed for exogenous junD sequences. All seven expressed these sequences a t levels approximately 1 to 30 times those of endogenous levels (Fig 4C) .
Similar analyses were performed on pSV,egr-1-dhfrtransfected F-MELCs. Seven of seven expressed levels of exogenous egr-1 transcripts that were 5-to 20-fold higher than endogenous levels (Fig 4D) .
In summary, our results confirm that the G-418/MTX sequential selection procedure is highly efficient as previously d e~c r i b e d . '~. '~.~~ In the present study, 34 of 35 clones examined contained unrearranged plasmid sequences and generally expressed them a t levels that were significantly higher than that of the respective endogenous gene. It should be noted that even those clones expressing the highest levels of jun transcripts grew a t rates that were indistinguishable from control F-MELCs (not shown).
Transfected jun sequences are unperturbed during DMSO induced diflerentiation. We have previously demonstrated that transfected c-myc and c-myb sequences are not regulated in response to DMSO in differentiating F-MELC. '6,24 This contrasts with the expression of transcripts originating from the endogenous gene, which continue to be regulated in a manner very much like that seen in untransfected F-MELCS.'~,'~ The loss of normal regulation of the transfected sequences presumably reflects the absence of critical promoter and intronic elements that have been shown to be critical for the expression of the normal To determine whether transfected sequences were regulated in response to DMSO, one clone each of c-jun, junB, junD, and egr-1-transfected F-MELCs were treated with 1.5% DMSO. RNAs were extracted a t different times and simultaneously examined for the expression of endogenous and transfected sequences. As seen in I n keeping with the above observations. transfected pSV,eRr-ldhfr sequences were also not modulated during DMSO treatment.
Chnsriritrive jun expression inhibirs F-MELC diferenrialion. To determine whether the enforced expression of jirn sequences exerted any effect on F-MELC differentiation.
clones described above along with several other randomly selected ones were treated with DMSO for 5 days and examined by benzidine staining for terminal dimerentiation. to DMSO. Individual F-MELC clones. transfected with tho indicated plasmid DNAs, were obtainod by limited dilution. Each was placed in medium containing 1.6% DMSO for 6 days, at which time terminal differentiation was assessed by staining for hemoglobin with the benzidine reagont.
For personal use only. on October 23, 2017 . by guest www.bloodjournal.org From and 7 gave rise to 6% to 40% benzidine-positive cells, whereas clones 1 through 4 gave rise to 30% to 88% benzidine-positive cells. Finally, in the case of pSVjunDdhfr-transfected F-MELC (Fig 4C) , clones 3 through 5 gave rise to 8% to 40% benzidine-positive cells, whereas clones 1 and 6 showed 42% and 60% benzidine positivity.
DJSCUSSION
The process by which F-MELCs become irreversibly committed to the pathway of terminal differentiation involves several distinct and sequential steps. At the earliest stage, it is necessary that the specific inducing agent be kept in contact with the undifferentiated cells for a minimal period of 12 to 16 hours after which time F-MELC are capable of autonomous differentiati~n.~' Numerous biochemical and molecular changes are associated with this reversible precommitment phase, which culminates in commitment and an irreversible progression to terminal differentiation without the requirement for continued exposure to the inducing agent. True commitment is associated with a finite number of additional cell doublings (usually four to eight) and the simultaneous acquisition of the differentiated phenotype.
Whereas much of the biochemical basis for the triggering of the precommitment and commitment phases remains to be elucidated, it is clear that cellular proto-oncogenes play a significant role. Initial observations that c-myc and c-myb gene transcripts were modulated during F -M E L C d i f f e r e n t i a t i~n~~.~~ led to experiments in which these genes, driven by foreign promoters, were reintroduced into the cells so as to override the intrinsic regulation of the endogenous In both cases, the result was a loss of inducible F-MELC differentiation. Additional evidence has suggested that these genes operate a t distinct levels, with c-myb serving to suppress differentiation a t a more proximal step.55
In the current study, we have investigated the role of the three known members of the jun proto-oncogene family on F-MELC differentiation. In each case, overexpression of these genes drastically changed the sensitivity of F-MELC to the inducer. Because the basal levels of c-jun transcripts in logarithmically growing F-MELCs are so low, we cannot be certain as to whether they are regulated as in the case of junB transcripts. We have also investigated the regulation of an additional early response gene, egr-1 .4' Like c-myc, c-fos. and jun family members, egr-1 is a member of the so-called immediate early response gene repertoire, induced in quiescent cells by serum or purified growth factors. egr-1 encodes a nuclear protein with three putative DNA binding zinc fingers and is likely to function as a transcription f a~t o r .~' Like junD, the levels of egr-1 transcripts do not change during F-MELC differentiation (unpublished observation, January 1990). egr-1 is different from jun family members, however, in that its overexpression is without apparent effect in F-MELC. Thus, the ability to inhibit F-MELC differentiation is a biologic property that is not necessarily shared by all immediate early response genes.
That all three jun members can inhibit F-MELC differentiation does not prove a direct role for each in this process. Rather, it is possible that this is the result of common physical or biochemical attributes shared by these three gene. 13-16.24.25 proteins. The ability to form homodimers and heterodimers with the c-fos gene p r o d~c t ,~~.~' coupled with the ability of these dimers to bind to the same DNA elements, suggests that the jun members may also share common biological proper tie^.^^,^^,^^ The recent finding that L-myc.can substitute for c-myc in inhibiting F-MELC differentiation, even though L-myc expression is not normally seen in these cells,56 provides some evidence for the functional overlap of related proto-oncogene products in this system.
The relative levels of jun expression required to achieve inhibition of F-MELC differentiation are quite high in comparison with c-myc and c-myb. Several non-mutually exclusive models, which take known properties of jun proteins into account, might account for this. (1) It is known that jun-fos heterodimerization is favored over jun-jun homodimerization and that the DNA binding of heterodimers is approximately 25-fold more efficient than that of hom~dimers.-'~-~' However, in the presence of large excesses of jun protein, increased jun-jun homodimerization would be favored and, a t the high constitutive levels seen here, might even predominate. This could result in the binding of the homodimer to DNA sites that are not normally occupied or in the displacement of jun-fos heterodimers or other transcription factors from normally occupied sites. (2) Excessive amounts of jun gene products may act as dominant negative mutants,57 depriving another jun member product from an integral association with c-fos or afoslike gene product. (3) c-jun has recently been shown to possess a negative regulatory domain near its N-termin~s.~' This region is highly conserved among all three jun proteins and its deletion in c-jun enhances the in vitro transcriptional activity of bacterially expressed protein. Thus, transfected jun members may be less efficient transcriptionally than c-myc or c-myb, although formal comparisons have not been made.
Phorbol ester tumor promoters such as TPA activate protein kinase C (PKC) and increase levels of c-jun mRNA by stimulating transcription of the c-jun gene and by stabilizing pre-existing mRNA t r a n s~r i p t s .~' .~~.~~ Phorbol esters are also potent inhibitors of F-MELC differentiation.60-62 We have previously shown that some DMSOresistant F-MELC lines have alterations in the overall cellular levels and subcellular distribution of PKC that mimic those seen in TPA-treated cells.63 The present findings suggest that an additional mechanism through which TPA might operate to inhibit F-MELC differentiation is through the chronic activation of jun family member genes.
